Can I take targeted drugs when I have ascitic fluid? How long will it take to be effective?
If there was ascitic fluid, whether or not to take the targeted medicine needed to be determined based on the specific cause. For example, in the case of liver cancer and hepatocelluar cancer with ascitic fluid caused by hepatectomy C, targeted therapy with sorafenib or lenvatini could be used. It might have some effect, but it might also be ineffective. During the medication, side effects such as liver function damage, kidney function damage, weight loss, rash, heart damage, high blood pressure, etc. should be closely observed. For patients with ascitic fluid during the active period of chronic hepatectomy B, targeted drugs such as Entecavir were mainly used to suppress the replication of the hepatectomy B virus. For patients with chronic hepatectomy C with ascitic fluid, targeted drugs such as sofobuvir, dasebuvir, gcarevir, ribavirin, etc. may be suitable, but these drugs have their own applications and contraindications. For example, sofobuvir is prohibited in children and pregnant women, and all these drugs need to be used under the guidance of a professional doctor. There was no definite time for how long it would take to be effective because it was affected by many factors, including individual differences in patients, severity of the disease, sensitivity to drugs, and so on. Read more exciting novels for free
Is it useful to take targeted drugs when cancer has ascitic fluid? How long is it?
Some targeted drugs had a certain effect on cancer ascitic fluid. For example, abdominal infusion of bevacizhu combined with chemotherapy could effectively reduce the accumulation of fluid in the abdominal cavity and control the production of abdominal fluid, but it was not clear how long it would take effect. For patients with liver cancer and hepatic ascitic fluid, targeted drugs such as sorafenib or lenvafenib may have a certain treatment effect, but there are also individual differences, and the specific time of effect cannot be determined. When using targeted drugs to treat ascitic fluid, it should be carried out under the guidance of a professional doctor. At the same time, it was necessary to actively treat the primary disease, strengthen nutrition, and pay close attention to the side effects of the drug. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it useful to take targeted drugs when cancer has ascitic fluid? What to do?
Some targeted drugs were useful for cancer ascitic fluid. For example, bevaczhu, as a targeted drug, could effectively reduce the accumulation of fluid in the abdominal cavity through abdominal infusion through combination chemotherapy, maintaining the balance of water in and out of the blood vessels, and thus controlling the production of abdominal fluid. Sorafenib or lenvatini could have a certain effect on the treatment of liver cancer, liver cancer, and hepatic ascitic fluid caused by liver cancer, but it might not be effective. If a cancer patient had ascitic fluid and was taking targeted drugs, if they had poor appetite, abdominal distension, etc., it might be the stimulation of the targeted drugs on the digestive tract mucus, resulting in abnormal secretion of gastric acid and digestive hormones, and slow intestinal distension. First, it can be determined whether there is a time relationship between poor appetite, abdominal distension, and taking targeted drugs. If there is a time relationship, the following measures can be taken: 1. Under the guidance of the doctor, take Jianwei Xiaoshi tablets, moperlin tablets, and digestive tablets. 2. You can take Chinese patent medicine Baohe pills and Xiangsha Yangwei pills (Chinese medicine is suitable for liver and stomach disharmony). 3. He massaged his abdomen, using a technique of pushing and rolling from top to bottom. If the abdominal distension is not relieved after the above measures are used, the body weight and abdominal circumference should be measured first to find out whether there is ascitic fluid, and the liver and kidney function should be rechecked to find out whether there is hepatic incompetence. Sometimes, in patients with liver tumors or previous liver cancer, taking targeted drugs would lead to an increase in ascitic fluid, which would lead to slow down of the digestive system. If the increase of ascitic fluid causes poor appetite and abdominal distension, you can ask the relevant doctor for help to protect the liver, diuretics, and protein replenishment. If it's just abnormal liver function that causes loss of appetite, you should actively treat liver protection. In addition, traditional Chinese medicine could also help in the auxiliary treatment of advanced cancer complicated with large amounts of ascitic fluid. For example, the prescription with poria cocos, grifola, lycopus, danshen, and milkvetch root as the main components was good at reducing water and swelling, helping to regulate the water balance in the body and reducing the discomfort caused by ascitic fluid. However, traditional Chinese medicine emphasized the treatment based on syndrome identification, so it was necessary to formulate an individual plan according to the patient's different conditions and physique. The prescription medicine must be used under the guidance of a professional doctor. Under the premise of using medication to control the ascitic fluid, it was necessary to actively treat the primary disease, strengthen nutrition, and eat more foods with high protein and vitamins. If the patient had any adverse reactions during the use of the targeted drug, they should immediately go to a regular hospital for treatment to avoid delaying the condition. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
How long will it take for targeted drugs to be effective for lung cancer?
Patients with lung cancer usually took targeted drugs for ten days, no more than forty days, and the effect would take effect in two to three days. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it always effective to take targeted drugs for lung cancer?
The effect of targeted drugs on lung cancer patients was not very good. Target drugs could not cure lung cancer. Although they could prolong survival time, they could not always be effective. There were very few driver mutations in lung cancer, so there were relatively few targeted drugs that could be used. When using targeted drugs, it was necessary to find the target of lung cancer and could not be used blindly. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
How long will it take to take targeted drugs after chemotherapy and discharge?
The targeted medicine usually took effect in three to four weeks, but the specifics varied from person to person. Some took effect in a few days, while others took months to see obvious effects. If the target was clear and the patient was more sensitive to the drug, the obvious effect might be seen in 2 - 3 days after taking the drug, and the clinical symptoms would be significantly improved. If the target was unclear or the patient was not sensitive to the drug, the effect would be slower. It might take 2 - 3 months to see the effect, but most patients could improve their symptoms in 3 - 4 weeks after taking the drug. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it effective to take targeted drugs after draining lung cancer in the late stage? How long is it effective?
For patients with late-stage lung cancer, the effectiveness of targeted drugs was related to many factors. The effectiveness of taking targeted drugs after draining the fluid could not be determined. First of all, an important prerequisite for targeted drugs to work was that genetic testing could find sensitive gene mutation sites. If the patient's genetic test results showed that there was a suitable target, the targeted drug could be effective. There was no direct causality between the operation of draining the fluid from late-stage lung cancer and the effectiveness of the targeted drug. Secondly, the duration of the targeted drug's effect on the patient also varied from person to person. Some patients may see obvious effects at the beginning of the drug, such as tumor shrinking, but due to the possible resistance of cancer cells, the effect may change over time. Some patients may have a good effect at first, but after a period of time (the specific length of time may vary from several months to several years), due to the adaptability of the cancer cells (such as replacing the cell pathway inhibited by the targeted drug through other pathways), the treatment effect will not be ideal. In addition, different types of lung cancer had different responses to targeted drugs. For example, the molecular characteristics of lung cancer were that even if genetic testing was done, common targets were rarely matched. In this case, the targeted drugs might not be effective. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it useful to take targeted drugs after chemotherapy and discharge? How long?
Compared with traditional chemotherapy drugs, anti-tumor targeted drugs had a completely different mechanism of action. At the same time, they had the significant advantages of high efficiency, low toxicity, and strong specialization. It was useful to use targeted drugs after discharge from chemotherapy, but the specific duration of effect would be affected by many factors. The drug resistance of targeted drugs was an important factor that affected their duration of action. Cancer cells would mutate. Although targeted drugs could accurately attack cancer cells, they could not identify all cancer cells in all directions. It was easy for drug resistance to occur. When cancer cells develop drug resistance, the effect of the targeted drug will decrease, and at this time, the drug may need to be changed. In order to detect drug resistance problems in time, regular assessment tests, such as tissue examination and blood test, were needed to adjust the medication in time. The individual differences between different patients would also affect the duration of the targeted drug. For cancer patients with specific gene mutations, such as cancer patients with egf-mutation, the targeted drug treatment effect would be more prominent, and the drug efficiency could reach 70%. Before targeted therapy, a comprehensive assessment was needed to understand whether there were specific changes in the genes. Patients who met the conditions would have a better effect if they used targeted drugs. In addition, the way the targeted drug was taken would also affect its effect and duration of effect. For example, the drug should be administered at the same time every day. This would allow the targeted drug to release a stable concentration of the drug, allowing the human body to absorb the drug's effects more deeply. If the timing of taking the medicine was messed up, the concentration of the medicine could not be released stably, which might affect the treatment effect. In short, taking targeted drugs after hospitalization was useful, but it was difficult to determine how long it would last. It was necessary to consider various factors such as drug resistance, individual differences, and medication methods. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
How long do you take targeted drugs for lung cancer?
The time taken for targeted treatment of lung cancer needed to be considered from both the patient's own condition and the progression of the disease. For patients with middle-stage lung cancer, it is recommended to take the first-generation targeted drug for 1.5 - 2 years or the third-generation targeted drug for 3 years. For patients with advanced lung cancer, as long as the targeted drug was effective, it was recommended to take it until the disease progressed. If drug resistance appeared, the targeted drug would need to be replaced. However, it should be noted that the premise of using targeted drugs was that the patient must have a clear target for treatment in the body, and there must be a specific drug targeting the target before targeted drug therapy could be carried out. Less than 20% of lung cancer patients could find targeted drugs. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Take the third generation of targeted drugs after the first generation of targeted drugs are resistant
After the first-generation targeted drug became resistant, the third-generation targeted drug could be considered. According to the data in document [2], after the first-generation targeted drug became resistant, only about 25% of patients had the opportunity to use osimertinib for second-line treatment. According to the study mentioned in document [4], the first-line use of osimertinib for the treatment of egfr-positive lung cancer, followed by comprehensive treatment methods such as chemotherapy and chemotherapy after drug resistance, the patient's overall survival time was 41.4 months, which was twice as long as the first-generation targeted drug. In addition, the document [5] mentioned the dual-target combination therapy plan, specifically the first-line treatment of the third-generation TKi osimertinib combined with the first-generation TKi gefitini, with a disease control rate of 100%. Therefore, for patients who were resistant to first-generation targeted drugs, third-generation targeted drugs might be an effective treatment option.
Is it useful to take targeted drugs for esophagus cancer metastasizing?
At present, a variety of targeted drugs were available for the treatment of esophagus cancer, including new small molecules multi-target Tyrosin Kinase Inhibition, drugs that targeted HEL2, cetuxed that targeted the egFr target, and bevacizumb that targeted the veg-like growth factor target, etc. There was also a combination of PD1 - 1 inhibition and targeted HEL2 for the treatment of cancer at the gastric-esophagus junction. Chinese studies have shown that as a new small-molecular multi-target Tyrosinase Kinase Inhibition, anlotinib and apitini have a certain effect in the treatment of esophagus cancer. The combination therapy of trastuzumab-targeted to HEL2 and PD1 inhibition drugs (such as pembrolizumab) combined with chemotherapy can be used as the first-line treatment for cancer of the gastroesophagus junction, advanced gastric cancer with HEL2 positive, and esophagus cancer. In the second-line treatment of China guidelines for the treatment of esophagus cancer, level II recommendations were given to anlotinib (Class 2A) and apitini (Class 3). However, there were no phase III clinical trials to prove that molecular targeted drugs could prolong the survival of patients with esophagus cancer. The effect of targeted therapy needed further study. In general, molecular targeted therapy had a certain clinical value for the treatment of patients with esophagus cancer, including those with metastasizing, but it still needed further in-depth research. These drugs must be used under the guidance of a professional doctor. It is not recommended for patients to buy and take them themselves to avoid serious adverse reactions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>